Clinical Trial

Switching to E-cigarettes in Smokers Not Interested in Quitting

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The objectives of this application are to 1) compare short- and long-term harm reduction and abuse liability potential of a nicotine salt pod-based electronic cigarettes (EC) in adult (AA) exclusive EC, dual cig-EC, and exclusive cig users, 2) characterize factors that predict who switches fully, partially, or not at all, and 3) examine if harm reduction can be further enhanced by treating dual users with varenicline (VAR) to eliminate cigarette smoking.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-01-19; most recent amendment 2025-12-24.
Status change: Not Yet Recruiting → Recruiting 2023-09-14
Trial Details
NCT Number NCT05703672
Lead Sponsor University of Kansas Medical Center
Conditions Smoking Reduction
Enrollment 500 participants
Start Date 2023-07-17
Primary Completion 2026-12-07 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-29